Risk Adapted SABR(SABR) in Stage I NSCLC And Lung Metastases

Clinical trial NCT01823003 · UNKNOWN

Trial details

NCT number: NCT01823003
Sponsor: Institut Català d'Oncologia
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Neoplasm Metastasis

Start date: 2012-06-01
Primary completion: 2019-12-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.